• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy

View Calendar

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Jason Goodman, USA

    Jason Goodman, USA

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • John Russo, USA

    John Russo, USA
    final3878

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Ali Var, Turkey

    Ali Var, Turkey

  • Hollister

    Hollister
    hollister

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Lombana, Spain

    Lombana, Spain

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Denis Blais, Canada

    Denis Blais, Canada

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Rob Tison, USA

    Rob Tison, USA

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • JP

    JP

  • Susan Anderson, USA

    Susan Anderson, USA

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Daniel Hare, USA

    Daniel Hare, USA

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Jon Newsome, USA

    Jon Newsome, USA

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login